![]() |
Combo therapy flavopiridol and cisplatin shows promise for recurrent ovarian cancer r
Mayo Clinic has reported promising interim results from a Phase II trial of a new combination therapy for patients with recurrent ovarian cancer that is resistant to platinum therapy.
More... |
| All times are GMT -7. The time now is 10:19 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021